Related references
Note: Only part of the references are listed.The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
Anne Catherine Sprynski et al.
BLOOD (2009)
The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways
Mohamed Rahmani et al.
BLOOD (2009)
The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma
Mathilde Romagnoli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Involvement of BH3-only proteins in hematologic malignancies
Junya Kuroda et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors
Ahmed Essaghir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1
Shuang Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
A global view of protein expression in human cells, tissues, and organs
Fredrik Ponten et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma
Eline Menu et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
BH3-only protein's Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma
Alejo A. Morales et al.
BLOOD (2008)
DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines
Ken Kawamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Multisite phosphorylation regulates Bim stability and apoptotic activity
Anette Hubner et al.
MOLECULAR CELL (2008)
Lysine acetylation: Codified crosstalk with other posttranslational modifications
Xiang-Jiao Yang et al.
MOLECULAR CELL (2008)
Bcl-2 family proteins and cancer
K. W. Yip et al.
ONCOGENE (2008)
BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
D. A. Fennell et al.
ONCOGENE (2008)
beta 1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells
L. A. Hazlehurst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Cinta Mestre-Escorihuela et al.
BLOOD (2007)
Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease
Luigia Lombardi et al.
GENES CHROMOSOMES & CANCER (2007)
Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
Laurence Catley et al.
BLOOD (2006)
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study
Jennifer M. Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells
Warren Fiskus et al.
BLOOD (2006)
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance
Patricia Maiso et al.
CANCER RESEARCH (2006)
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells
T Strömberg et al.
BLOOD (2006)
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
E Menu et al.
BLOOD (2006)
Epigenetics of prostate cancer: beyond DNA methylation
W. A. Schulz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
DNA methylation and histone modifications: teaming up to silence genes
F Fuks
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma
TE Fandy et al.
NEOPLASIA (2005)
The key to development: interpreting the histone code?
R Margueron et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells
A Essafi et al.
ONCOGENE (2005)
Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells
P Gomez-Bougie et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model
E Menu et al.
BRITISH JOURNAL OF CANCER (2004)
Rational siRNA design for RNA interference
A Reynolds et al.
NATURE BIOTECHNOLOGY (2004)
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
CS Mitsiades et al.
CANCER CELL (2004)
The clinical application of targeting cancer through histone acetylation and hypomethylation
J Gilbert et al.
CLINICAL CANCER RESEARCH (2004)
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
LP van der Heide et al.
BIOCHEMICAL JOURNAL (2004)
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors
XY Pei et al.
CLINICAL CANCER RESEARCH (2004)
The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells
P Gomez-Bougie et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line
C Pompeia et al.
CANCER RESEARCH (2004)
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
F Luciano et al.
ONCOGENE (2003)
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy
K Breckpot et al.
JOURNAL OF GENE MEDICINE (2003)
Multiple myeloma biology: lessons from the 5TMM models
K Vanderkerken et al.
IMMUNOLOGICAL REVIEWS (2003)
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
T Standal et al.
BLOOD (2002)
Insulinlike growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk
YW Qiang et al.
BLOOD (2002)
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
PF Dijkers et al.
CURRENT BIOLOGY (2000)
Share Paper
